Recent Developments of Target Based Coumarin Derivatives as Potential Anticancer Agents

Area of Science:

• Medicinal Chemistry
• Organic Chemistry
• Pharmacology

Background:

• Cancer is a leading global cause of death, with 9.6 million deaths in 2018.
• Multidrug resistance and lack of selectivity in current cancer treatments necessitate novel therapeutic agents.
• Coumarin scaffolds are widely utilized for developing effective anticancer drugs due to their versatile mechanisms.

Purpose of the Study:

• To review target-based coumarin derivatives for cancer therapy.
• To highlight diverse mechanisms of action for coumarin-based anticancer agents.
• To discuss synthetic strategies for developing coumarin derivatives.

Main Methods:

• Literature review of coumarin derivatives targeting cancer.
• Analysis of Structure-Activity Relationships (SAR) for coumarin compounds.
• Focus on coumarins targeting specific proteins like Galectin-1, Carbonic anhydrases, and Tubulin.

Main Results:

• Coumarin derivatives exhibit potent anticancer activity through various mechanisms.
• Target-based design, including Galectin-1, Carbonic anhydrases, and Tubulin inhibition, shows efficacy.
• SAR studies guide the development of coumarins with enhanced potency and reduced side effects.

Conclusions:

• Coumarin derivatives represent a promising class of anticancer agents.
• Target-specific coumarin development offers a viable strategy for overcoming drug resistance.
• Further research into synthetic strategies can accelerate the discovery of novel coumarin-based cancer therapeutics.